Millions Could Benefit from New, Noninvasive Treatments Spotlighted at 2nd International MR-guided Focused Ultrasound Symposium

Press releases may be edited for formatting or style | October 05, 2010

Stem cell activation - To be effective, therapeutic stem cells must home in on target tissue, much like moths to a flame. However, existing pathologies prevent most target tissue from releasing enough chemo-attractants to draw in stem cells, thus limiting treatment success. Researchers from the National Institutes of Health will describe how they have used pulsed focused ultrasound to generate local release of chemo-attractants, potentially increasing the homing instincts of bone marrow stromal cells.

Polefrone says the symposium will also feature leading edge research related to Benign Prostatic Hyperplasia (BPH), pancreatic and liver cancer, bone tumors, uterine fibroids, targeted drug delivery and various aspects of MR-guided focused ultrasound technology.

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

Program details, reporter inquiries
To view the complete symposium programs, click here. To view the list of abstracts included in the October 19 poster session, click here. Reporters interested in attending the symposium should contact the Foundation's Director of Communications, Ellen C. McKenna.
###

About the Focused Ultrasound Surgery Foundation
Founded in 2006 and based in Charlottesville, Virginia, the Focused Ultrasound Surgery Foundation is dedicated to accelerating research and development of patient treatments using one of today's most revolutionary and promising medical technologies: noninvasive Magnetic Resonance-guided Focused Ultrasound (FUS). The Foundation's work is motivated by the belief that FUS treatments could become the ultimate in minimally invasive surgery, serve as a viable alternative to radiation therapy and offer a new platform for precise drug delivery - uses that could alleviate suffering, save lives and quicken recovery times for millions of patients worldwide.

Back to HCB News